Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Pharmaxis Ltd.
DescriptionSmall molecule lysyl oxidase-like 2 (LOXL2) inhibitor
Molecular Target Lysyl oxidase-like 2 (LOXL2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver fibrosis
Indication DetailsTreat liver fibrosis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today